Gastroenterology Elsewhere

Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients

Volume 27 · Issue 2 Publish Date: March 15, 2016
Full Text PDF
DOI
Alp Serhat Kahveci
Division of Gastroenterology, University of Missouri, Columbia, Missouri, USA
Veysel Tahan
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, Missouri, USA
Kahveci, A. S., & Tahan, V. (2016). Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients. Turkish Journal of Gastroenterology, 27(2), 205–206. https://doi.org/10.5152/tjg.2016.160000
Full Text Full Text PDF

Abstract

Hepatitis C, a blood-borne virus responsible for inflammation of the liver, is characterized by six major genotypes, 1-6.

Most read articles by the same author(s)

1 2 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 27 · Issue 2
Pages 205-206
History
Published Online March 15, 2016
License
Copyright
Affiliations
Alp Serhat Kahveci
Division of Gastroenterology, University of Missouri, Columbia, Missouri, USA
Veysel Tahan
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, Missouri, USA
Cite this Article
Kahveci, A. S., & Tahan, V. (2016). Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients. Turkish Journal of Gastroenterology, 27(2), 205–206. https://doi.org/10.5152/tjg.2016.160000
Outlines